Cargando…
Any Role of PIK3CA and PTEN Biomarkers in the Prognosis in Oral Squamous Cell Carcinoma?
Oral squamous cell carcinoma (OSCC) accounts for 95% of the lesions in the oral cavity. Despite development in OSCC management, the outcome is still unsatisfactory. Identification of new therapies in OSCC is urgently needed. One objective of such treatment may be a signaling pathway of phosphatidyli...
Autores principales: | Starzyńska, Anna, Adamska, Paulina, Sejda, Aleksandra, Sakowicz-Burkiewicz, Monika, Adamski, Łukasz Jan, Marvaso, Giulia, Wychowański, Piotr, Jereczek-Fossa, Barbara Alicja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761816/ https://www.ncbi.nlm.nih.gov/pubmed/33287350 http://dx.doi.org/10.3390/life10120325 |
Ejemplares similares
-
Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature review
por: Starzyńska, Anna, et al.
Publicado: (2020) -
The B7 family molecules in oral squamous cell carcinoma: a systematic review. Part I: B7-H1 (PD-L1) and B7-DC (PD-L2)
por: Starzyńska, Anna, et al.
Publicado: (2020) -
Multiple odontogenic keratocysts in Ehlers–Danlos syndrome: a rare case report
por: Starzyńska, Anna, et al.
Publicado: (2021) -
High PD-L1 Expression on Tumor Cells Indicates Worse Overall Survival in Advanced Oral Squamous Cell Carcinomas of the Tongue and the Floor of the Mouth but Not in Other Oral Compartments
por: Adamski, Łukasz Jan, et al.
Publicado: (2021) -
ZNF-281 as the Potential Diagnostic Marker of Oral Squamous Cell Carcinoma
por: Starzyńska, Anna, et al.
Publicado: (2021)